Perfluorophenyl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oate, 95%, 1g

(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, 95.0%, 25g

(4S,4'S)-4,4'-Diisopropyl-1,1'-bis(3-isopropylphenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

Filtration unit Rapid-Flow with PES membrane Pore size 0.2 μm, 1000 ml, 1000 ml, 90 mm, 12 Piece(s)

(4-(trans-4-Pentylcyclohexyl)phenyl)boronic acid, 95.0%, 25g

N-(4-Methoxyphenyl)acetamide, 98.0%, 25g

2,6-Diiodo-4-nitroaniline>98.0%(GC)5g

Glucotropaeolin Potassium Salt>95.0%(HPLC)10mg

Coomassie Brilliant Blue G-250 [for Electrophoresis]5g

3-Fluoro-4-methoxyphenylboronic Acid (contains varying amounts of Anhydride)1g

(1-(4-Methylphenyl)-3-(4-(methylthio)phenyl)-1H-pyrazol-4-yl)methanol, 250mg

(3-Cyano-5-(trifluoromethyl)phenyl)boronic acid, 95.0%, 5g

(3-Chloro-4-(pyrrolidine-1-carbonyl)phenyl)boronic acid, 95.0%, 500mg